Thus, it appears that the inhibitory effects of XCHT on high-glucose-induced ROS generation could potentially disturb stimulation of TGF-β1 and the resulting ECM proteins accumulation, thereby partly explaining the drug's renal protective effects in diabetic nephropathy. Here, TGFB1 is linked to diabetic kidney disease.